Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
24-4
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
24-4
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #85310
advertisement
Brubaker JW
14
Showing records 1 to 14 |
Display all abstracts from
Brubaker JW
117008
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Bacharach J
American Journal of Ophthalmology
2024; 263: 23-34
118281
Difficult decisions, filtration surgery, and the heartbreak of the numerator
Samuelson TW
Journal of Cataract and Refractive Surgery
2024; 50: 97-103
117008
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Brubaker JW
American Journal of Ophthalmology
2024; 263: 23-34
118281
Difficult decisions, filtration surgery, and the heartbreak of the numerator
De Francesco T
Journal of Cataract and Refractive Surgery
2024; 50: 97-103
117008
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Evans DG
American Journal of Ophthalmology
2024; 263: 23-34
118281
Difficult decisions, filtration surgery, and the heartbreak of the numerator
Ahmed IIK
Journal of Cataract and Refractive Surgery
2024; 50: 97-103
117008
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Lu F
American Journal of Ophthalmology
2024; 263: 23-34
118281
Difficult decisions, filtration surgery, and the heartbreak of the numerator
Gedde SJ; Paranjpe VR
Journal of Cataract and Refractive Surgery
2024; 50: 97-103
117008
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Odani-Kawabata N
American Journal of Ophthalmology
2024; 263: 23-34
118281
Difficult decisions, filtration surgery, and the heartbreak of the numerator
Singh K
Journal of Cataract and Refractive Surgery
2024; 50: 97-103
117008
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Yamabe T
American Journal of Ophthalmology
2024; 263: 23-34
118281
Difficult decisions, filtration surgery, and the heartbreak of the numerator
Brubaker JW
Journal of Cataract and Refractive Surgery
2024; 50: 97-103
117008
Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Wirta DL
American Journal of Ophthalmology
2024; 263: 23-34
118281
Difficult decisions, filtration surgery, and the heartbreak of the numerator
Grover DS; Fellman RL; Zhang AD; Barton K
Journal of Cataract and Refractive Surgery
2024; 50: 97-103
Issue
24-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept